Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Precancerous Conditions 4Breast Neoplasms 4Neoplasms 2Adenomatous Polyposis Coli 2Unspecified Adult Solid Tumor, Protocol Specific 1Tobacco Use Disorder 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pain 1Melanoma 1Leukoplakia, Oral 1Inflammation 1Hypertension 1Desmoid Tumors 1Coproporphyria 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Imatinib Mesylate 3nirogacestat 2vactosertib 1strattice 1entinostat 1Vinblastine 1Toremifene 1Taxes 1Tamoxifen 1Surveys and Questionnaires 1Sunitinib 1Sulindac 1Sorafenib 1Sirolimus 1Radiotherapy 1Nivolumab 1Methotrexate 1Fentanyl 1Data Collection 1Cyclophosphamide 1Blood Specimen Collection 1Albumin-Bound Paclitaxel 1Abdominoplasty 14-hydroxy-N-desmethyltamoxifen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Desmoid Tumors × Sulindac × Clear all
NCT00068419 2020-02-19

Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor

Children's Oncology Group

Phase 2 Completed
70 enrolled 11 charts
Sarcoma

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡